Yu, Mei-Ching
Rich, Peter
Foreman, Liberty
Smith, Jennifer
Yu, Mei-Shiuan
Tanna, Anisha
Dibbur, Vinod
Unwin, Robert
Tam, Frederick W. K.
Article History
Received: 9 June 2016
Accepted: 22 May 2017
First Online: 4 July 2017
Competing Interests
: Prof. FWKT has received research project grants from AstraZeneca Limited, Baxter Biosciences, Boehringer Ingelheim, and MedImmune, and has consultancy agreements with Rigel Pharmaceuticals, Novartis and Baxter Biosciences. Prof. RJU is currently on secondment as Chief Scientist to Cardiovascular and Metabolic diseases (iMed CVMD) R&D, AstraZeneca, Gothenburg, Sweden. All of the other coauthors declare no competing financial interests.